CTOs on the Move

Centre International d'arte contemperain de Mont

www.ciac.ca

 
Centre International d'arte contemperain de Montreal is a Montreal, QC-based company in the Non-profit sector.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.ciac.ca
  • 2565 Berri St Ste 230
    Montreal, QC CAN H2X 4A6
  • Phone: 514.288.0811

Executives

Name Title Contact Details

Similar Companies

Job Path

Job Path is a New York, NY-based company in the Non-Profit sector.

Cerebral Palsy Association of Middlesex

For more than five decades, the Cerebral Palsy Association of Middlesex County has been committed to enhancing the lives of persons with disabilities. With a dedicated staff of more than 500 employees, in 25 locations throughout the State, and a budget

Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Physicians Committee for Responsible Medicine

Founded in 1985, the Physicians Committee for Responsible Medicine is a nonprofit organization that promotes preventive medicine, conducts clinical research, and encourages higher standards for ethics and effectiveness in research.

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is a nationwide network of people dedicated to working together to advance research through our advocacy efforts on Capitol Hill as well as directly funding pancreatic cancer research, support patients through our Patient & Liaison Services program and create hope through our Community Outreach volunteer program all benefiting those affected by pancreatic cancer and the entire pancreatic cancer community.